Equities
Health CarePharmaceuticals and Biotechnology
  • Price (USD)262.67
  • Today's Change-20.62 / -7.28%
  • Shares traded15.00
  • 1 Year change+49.10%
  • Beta0.4941
Data delayed at least 15 minutes, as of Feb 19 2026 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2025202520242023
REVENUE AND GROSS PROFIT
Total revenue38929151
OPERATING EXPENSES
Cost of revenue total23203.09
Selling, general and admin. expenses, total14711498
Depreciation/amortization------
Unusual expense(income)038(88)
Other operating expenses, total------
Total operating expense22822560
Operating income16166(9.73)
Other, net------
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes1899513
Provision for income taxes(15)6.201.97
Net income after taxes2058911
Minority interest------
Net income before extra. Items2058911
Total extraordinary items------
Net income2058911
Inc.avail. to common excl. extra. Items2058911
Inc.avail. to common incl. extra. Items2058911
EPS RECONCILIATION
Basic/primary weighted average shares292927
Basic/primary eps excl. extra items7.083.120.40
Basic/primary eps incl. extra items7.083.120.40
Dilution adjustment------
Diluted weighted average shares303028
Diluted eps excl. extra items6.843.000.39
Diluted eps incl. extra items6.843.000.39
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental----0
SUPPLEMENTAL INCOME
Depreciation, supplemental5.726.005.01
Total special items038(88)
NORMALISED INCOME
Normalized income before taxes189133(75)
Effect of special items on income taxes02.44(31)
Income tax excluding impact of special items(15)8.63(29)
Normalized income after tax205124(46)
Normalized income avail. to common205124(46)
Basic normalized EPS7.084.34(1.69)
Diluted normalized EPS6.844.18(1.66)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.